Best Deep Comm Podcasts (2024)

1
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates 35:21

1d ago35:21

35:21

Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."…

1
Innovative Internal Communications: A Curious Route 23:44

5h ago23:44

23:44

In this episode of WordBirds, Chris Willis interviews Joanna Parson, CEO of The Curious Route and author of Innovative Internal Communications. Why it matters: Joanna’s journey from a curious thinker to a leading internal communications expert offers valuable insights and practical advice on rethinking internal comms strategies. Driving the news: J…

1
Caleb Smith on Working for 3 GOP House Speakers 1:02:18

12h ago1:02:18

1:02:18

Caleb Smith may be the only political operative who's worked for three consecutive US House Speakers. During over a decade on Capitol Hill, he worked with Speakers Boehner, Ryan, and McCarthy. In this conversation, Caleb talks his path to politics from managing a legislative race in small-town Kentucky to working in some of the most prime real esta…

1
322: A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids 32:57

17h ago32:57

32:57

STAT reporter Matt Herper joins us to break down all the angles of this week's tumultuous week in cancer immunotherapy, including his up-close look at Summit co-CEO Bob Duggan. We also discuss the latest news in the life sciences, including Moderna pruning its pipeline and its spending, plus results from a study that tested a GLP-1 drug in children…

1
Communicating in a Crisis: Leading with Clarity & Purpose 29:17

2d ago29:17

29:17

Navigating crisis communications In this episode of WordBirds, Chris Willis sits down with communications expert Roberto Munoz (Fannie Mae, HSBC, Tesco) to explore the critical role of crisis communications. Why it matters: Effective crisis communication can be the difference between maintaining your brand's reputation and losing it. Roberto shares…

1
321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target 35:18

8d ago35:18

35:18

We discuss the next big trend in obesity drug development — treatments that target the amylin hormone. Companies argue that these types of drugs could lead to less nausea and muscle loss, and the first big readout is coming later this year. We also chat about an upcoming presentation from Summit Therapeutics on its cancer drug that beat Merck’s Key…

1
Reimagining Communications: From Tactical Function to Strategic Powerhouse 31:23

9d ago31:23

31:23

We're back with Season 6! And we're kicking off with Eleanor Hawkins, Axios Communications Strategist and writer of the Communicators newsletter. Eleanor spent years as a communicator in media and politics and now covers the topics and trends that impact how organizations, leaders, and employers communicate. Listen in to hear Eleanor and Chris dig …

1
17: All good things.... 34:37

9d ago34:37

34:37

Here we are... the last ever Talking Comms podcast. BUT WAIT! We're not sad it's over, in fact we're evolving Talking Comms - as you'll hear in the episode - into a full bespoke workshop for comms pros. Hit us up at talkingcommspod@gmail.com if you want to make podcasts for your organisation. As for the episode, we get a bit wistful about previous …

1
2024 Digital Trends & Best Practices with Mark Jablonowski, President & CTO of DSPolitical 47:47

10d ago47:47

47:47

Mark Jablonowski is the President and Chief Tech Officer of DS Political - one of the leading digital ad firms for Democratic campaigns and progressive causes. Mark's roots in campaign tech go back to 2004 and he was deeply involved in the Obama 2008 primary and general election digital innovations. In this conversation, Mark talks his own path to …

1
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy 37:34

16d ago37:34

37:34

STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.…

1
Bryan Bennett, of Navigator Research, on Findings from Recent Polling of 4,000 Young Voters 59:54

23d ago59:54

59:54

Bryan Bennett is the Senior Director for Polling & Analytics at The Hub Project and a pollster for Navigator Research who recently spearheaded a 4,000 sample survey among voters 18-34. In this conversation, Bryan talks his path to politics and polling and goes deep on this new massive project among younger Americans. This data unearths new findings…

1
Season 2 Episode 2 Kimberly Govea - Boost Your Training 48:05

30d ago48:05

48:05

In this episode, the focus is on the significance of incorporating training enhancements throughout all stages of your initial and ongoing instruction. Our host and guest will delve into the importance of recognizing various learning styles and using creativity to guarantee the effectiveness of your training program. They will discuss numerous stra…

1
From "Say More": What Happens When AI Decides Your Medical Coverage 22:42

1M ago22:42

22:42

This week, STAT's Casey Ross and Bob Herman joined the Boston Globe's "Say More" podcast to talk about their reporting on AI and Healthcare. We're sharing that episode here with you now. Enjoy!By STAT

1
319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides 34:07

22d ago34:07

34:07

It's a guest-free episode this week, giving Allison, Adam and Elaine ample time to chat about the management shakeup at BioMarin, including the announcement that James Sabry, the former Roche dealmaker, was joining the company as its new chief business officer. We can't seem to go a week without talking about GLP-1 medicines, so in true form, Elain…

1
Re-connecting with Election Analyst David Nir for the Launch of The Downballot 1:09:48

26d ago1:09:48

1:09:48

Catching up this week with return guest David Nir, who for over a decade has been an influential election analyst and the creator of Daily Kos Elections. Within the past week, David has moved his analysis to an independent site - now called The Downballot. In this conversation, David provides an update on his transition: what is happening, why now,…

1
318: Drug pricing drops & psychedelics under fire 21:16

29d ago21:16

21:16

STAT’s chief Washington correspondent Rachel Cohrs Zhang joins us to discuss the discounts and how this first round of negotiations between pharmaceutical companies and Medicare officials played out. After that, we chat with our colleague Meghana Keshavan about the latest news in the psychedelics world, including the retraction of three research pa…

1
What India Needs: Future of India's ageing population with Rajinish Menon 1:52:13

1M ago1:52:13

1:52:13

Send us a text By 2050, one in five Indians will be a senior citizen, amounting to a remarkable 347 million elderly individuals. In this episode, Shutapa Paul engages with Rajinish Menon, Founder & CEO of Sukino Healthcare Solutions, to explore this demographic shift and the current state of senior citizens in India. How prepared are we to tackle t…

1
317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision 28:52

2M ago28:52

28:52

STAT's Washington Correspondent John Wilkerson joins us to discuss the first round of drug pricing negotiations under the Inflation Reduction Act, which will wrap up by September 1. We also cover the latest news in the life sciences including the merger of AI drug development companies Recursion Pharmaceuticals and Exscientia, Novo Nordisk's decisi…

1
Tucker Eskew, Political & Corporate Comms Expert 1:04:26

1M ago1:04:26

1:04:26

Communications expert Tucker Eskew has been a participant in some of the most seminal moments in American political history over the course of the past 30+ years...a protege of the famed Republican strategist Lee Atwater, senior aide to the Bush 2000 win over John McCain in the fractious South Carolina primary, working in the White House the mornin…

1
316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates 34:15

2M ago34:15

34:15

Andrew Joseph, STAT's Europe correspondent, joins us to talk about his special report on the 40-year quest to develop the world's first malaria vaccines. We also cover the latest news in the biotech industry, including Sarepta Therapeutics' move to censor a patient video, data from a new Duchenne gene therapy, and a campaign by Mount Sinai to stifl…

1
315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves 32:46

2M ago32:46

32:46

What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Tara Bannow, our hospitals and insurance reporter, joins us to talk about a new investigation that shows how UnitedHeal…

1
Deep Inside the World of Political Donors with David Callahan 1:03:37

2M ago1:03:37

1:03:37

David Callahan is a prolific creator and thinker within Democratic politics. He helped start the progressive think tank Demos in the late 90s, founded the media outlet Inside Philanthropy as a Consumer Reports of sorts into the world of charitable giving, and more recently created Blue Tent - an advisory group to help progressive donors get the mos…

1
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages 33:02

2M ago33:02

33:02

Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss the latest news in the biopharma industry, including the latest developments in the ongoing controversy surrounding Cassava’s Alzheimer’s drug, short…

1
313: Biotech layoffs, founder-focused VC, & a big pharma exit 34:52

2M ago34:52

34:52

STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotech incubator Curie.Bio and how they hope to “free the founders.” We also discuss a big change in Pfizer’s leadership and the debate over a new side eff…

1
What India Needs: Indian Bureaucracy Unveiled with Anil Swarup 1:04:40

2M ago1:04:40

1:04:40

Send us a text What makes a “good” bureaucrat? In this episode, we delve into the mind and life of an Indian bureaucrat. Featuring Anil Swarup, former Coal and Education Secretary, Government of India, this episode charts almost four decades of his extensive bureaucratic expertise. Discover Anil Swarup’s insights on navigating the delicate dynamics…

1
Lisa MacLean, Founder of Moxie Media - the First Female-Founded Political Direct Mail Firm 45:48

2M ago45:48

45:48

Lisa MacLean, founder of Moxie Media - the first female-founded political direct mail firm in the U.S - talks her path to politics...starting in St Louis and then Vassar, to impactful DC internships, managing campaigns in California and eventually starting her own mail firm in the late 1990s that recently celebrated its 25th Anniversary. In this co…

1
Pro Politics Re-Release: Kinky Friedman from June 04, 2021 34:52

3M ago34:52

34:52

Kinky Friedman passed away yesterday, June 27 2024. This is a re-release of a Pro Politics Podcast episode with Kinky originally released June 4, 2021. Kinky Friedman wore many hats in his 79 years - country music artist, bestselling novelist, political candidate, animal welfare activist, friend of multiple US Presidents, and a Texas and American i…

1
312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate 28:33

3M ago28:33

28:33

STAT health tech reporter Brittany Trang guest co-hosts "The Readout LOUD" this week, where we discuss AI for drug development, the latest in the H5N1 bird flu outbreak, a surprise entrant to the GLP-1 field, and more news in the life sciences. And STAT chief Washington correspondent Rachel Cohrs Zhang joins the podcast to talk about a new proposal…

1
Debbie Cox Bultan, CEO of NewDEAL, on 30+ Years Working in the Center-Left 39:54

3M ago39:54

39:54

Debbie Cox Bultan has been working in Democratic politics for more than 30 years, including more than a decade at the Democratic Leadership Council and then helping start NewDEAL where she is now the CEO. At NewDEAL, she works to connect pro-growth progressive leaders and help raise their profiles and amplify their ideas. In this conversation, she …

1
311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review 34:10

3M ago34:10

34:10

STAT reporter Jason Mast joins us to discuss Anthony Fauci's memoir "On Call," which was published this week. Hosts Allison DeAngelis and Adam Feuerstein also dissect Alnylam's forthcoming clinical trial data and take stock of how the biotech markets are succeeding and potentially falling flat midway through the year. For more on Fauci's memoir "On…

1
310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism) 38:46

3M ago38:46

38:46

STAT's Nicholas Florko joins to explain what it means to be a reporter writing about the commercial determinants of health. Hint: Florko's most recent stories focus on weed, vapes, and raw milk. And instead of being chained to a desk, he often drives around to convenience stores and buy bad stuff — all in the name of good journalism. But first, co-…

1
What India Needs: Tackling India's Water Crisis with Vikas Bramhavar 1:24:51

3M ago1:24:51

1:24:51

Send us a text In this episode, we dive into the water crisis faced by the Indian cities—a wake-up call for 100+ cities that could face the same by 2050. Join us as we speak with Vikas Bramhavar, founder of BOSON Whitewater, to uncover the causes of this crisis, the transformative power of wastewater management, and how we can save every drop for a…

1
Congressman Mickey Edwards...From Conservative Insurgent to House Leadership to Nonpartisan Iconoclast 57:18

3M ago57:18

57:18

Mickey Edwards served 16 years in Congress, as the first Republican to represent his Oklahoma City-based district in almost 50 years. Prior to his time in the House, he'd already made a mark as a leader in early days of "New Right" conservative organizations like the Young Republicans and Heritage Foundation. In this conversation, he talks his earl…

1
309: Psychedelics at the FDA, ASCO recap, & MorphoSys update 29:34

4M ago29:34

29:34

STAT colleague Meghana Keshavan joins us to dissect Lykos Therapeutics' meeting with an FDA advisory committee. We also discuss the latest news in the health and life sciences, including stories from major biotech conferences. To learn more about Lykos' advisory committee meeting, go here; for more on the tumult at BIO, go here; for a recap of ASCO…

Podcasts Worth a Listen

Deep Comm Podcasts

Podcasts Worth a Listen

Quick Reference Guide